Edition:
India

Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,579.45INR
23 May 2017
Change (% chg)

-- (--)
Prev Close
Rs2,579.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
413,750
52-wk High
Rs3,689.85
52-wk Low
Rs2,521.95

REDY.NS

Chart for REDY.NS

About

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and... (more)

Overall

Beta: 0.15
Market Cap(Mil.): Rs432,694.09
Shares Outstanding(Mil.): 165.74
Dividend: 20.00
Yield (%): 0.77

Financials

  REDY.NS Industry Sector
P/E (TTM): -- 29.41 30.38
EPS (TTM): -- -- --
ROI: -- 13.85 13.36
ROE: -- 14.79 14.50

BRIEF-Dr.Reddy's Laboratories says USFDA approved launch of doxorubicin hydrochloride liposome injection in U.S.

* Announces USFDA approval for launch of doxorubicin hydrochloride liposome injection in U.S. Market Source text - (http://bit.ly/2qQ6RC6) Further company coverage:

17 May 2017

BRIEF-India's Dr.Reddy's Laboratories March-qtr consol profit rises about three-fold

* Consensus forecast for March quarter consol profit was 4.27 billion rupees

12 May 2017

BRIEF-Dr. Reddy's Labs launches Ezetimibe and Simvastatin tablets in U.S. market

* Says launch of Ezetimibe and Simvastatin tablets in U.S. market Source text for Eikon: Further company coverage:

27 Apr 2017

BRIEF-Fresenius sees no change in relationship of Merck KGaA's unit with partner Dr Reddy's

* Fresenius ceo sturm says we've had a good q1 but will not provide details

25 Apr 2017

BRIEF-Dr.Reddy's Laboratories announces launch of progesterone capsules in the U.S.

* Dr.Reddy's Laboratories - announces the launch ofprogesterone capsules in the U.S. market". Source text: (http://bit.ly/2pLTt0P) Further company coverage:

21 Apr 2017

BRIEF-Dr. Reddy's Labs, Integra Lifesciences sign deal to market Duragen products in India

* Co, Integra Lifesciences enter agreement to market, distribute Duragen plus and suturable duragen dural regeneration in India

27 Mar 2017

BRIEF-Cytosorbents Corp enters into a partnership with Dr. Reddy's laboratories

* Have entered into a partnership with Dr. Reddy's laboratories ltd for South African market

16 Mar 2017

BRIEF-Dr.Reddy's Labs gets form 483 with 3 observations from USFDA for audit of Miryalaguda plant

* Says the audit of API manufacturing plant at Miryalaguda, by the US FDA, has been completed on February 21, 2017

21 Feb 2017

BRIEF-Dr.Reddy's Labs says no claims against co for monetary damages

* Clarifies on news item "Dr. Reddy's announces US district court's opinion relating to patent infringement"

17 Feb 2017

BUZZ-India's Dr. Reddy's Labs hits over 1-year low; firm's drug infringes U.S. patents

** Shares of Dr Reddy's Laboratories fall as much as 3.9 pct, their lowest since Jan 22, 2016

16 Feb 2017

More From Around the Web

Earnings vs. Estimates